Clinical Trials Browser

Phase 1/2 × Terminated × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all

NCT02543749 2023-02-09

DC Vaccination in CML

Phase 1/2 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive